The Ohio State University College of Veterinary Medicine is excited to be hosting the 2016 Merial-NIH National Veterinary Scholar Symposium to be held July 28-31, 2016 in Columbus, Ohio. This symposium is the keystone meeting that brings together over 450 DVM students from the US and Canada; nearly 200 faculty mentors who participate in NIH T35 and T32 training, and other publically funded research training programs throughout the United States and Canada; and accredited foreign schools of veterinary medicine. Merial, the NIH Office of the Director, and several private sponsors including Howard Hughes Medical Institute (HHMI) and the Burroughs Wellcome Fund, have made essential investments to fund this program, and thereby invest in attracting and training highly motivated DVM students to conduct research early in their career. This early career training is critical in the development of the best and brightest next generation of veterinarians and veterinarian researchers, and to equip them to meet the complex health challenges facing humans, animals and the environment.
The Society of Toxicologic Pathology is sponsoring the concurrent breakout session entitled, “Research Career Pathways: Three Journeys” This session will take place on the afternoon of Friday, July 29, 2016. We have confirmed our three speakers: Dr. Krista La Perle (The Ohio State University), Dr. Sarah Tannehill-Gregg (Takeda Pharmaceuticals), and Dr. Joelle Fenger (The Ohio State University).
For more information about the Merial-NIH National Veterinary Scholars Program and the Annual Symposium, refer the following links:
http://www.merialscholars.com/Pages/national-symposium.aspx# - check back for details as they become available
Keynote Speaker Professor Dr. Ab Osterhaus
As professor of Virology in Rotterdam and Utrecht, The Netherlands, and in Hannover, Germany, Ab Osterhaus has a long track record as scientific researcher and PI of numerous major scientific projects.
At Erasmus MC he ran the >40 persons virology diagnostic lab and the > 100 persons virology research lab. His research programme followed a novel integrated “viroscience” concept, bringing together world leading scientists in molecular virology, immunology, epidemiology, pathogenesis, and intervention studies on human and animal virus infections.
After having handed over the chairmanship of the Erasmus MC Viroscience lab in 2014, he is currently establishing new One Health Institutes in Utrecht and Hannover.
Major performances include the discovery of more than 50 new viruses of humans and animals (e.g. human metapneumovirus, human coronaviruses, influenza viruses), elucidation of the pathogenesis of major human and animal virus infections, and development of novel intervention strategies. This has enabled health authorities like WHO, to effectively combat disease outbreaks like SARS and avian influenza. The spinoff, Viroclinics Biosciences BV, is another societally relevant success, allowing effective testing and refining of diagnostic tools and other intervention strategies.
Awards, prizes, guest lecture invitations, (co-)organisership of international meetings and editorships of scientific journals further highlight his international recognition. He has acted as PhD mentor for more than 75 students, holds several key patents and is the author of more than 1100 papers in peer-reviewed journals, together cited more than 50,000 times, and his current H index is 97. He is Editor-in-Chief of two major Elsevier Journals. Most of all, Ab Osterhaus firmly believes scientists have a role to play in translating their knowledge for the benefit and protection of society.